Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Clinical Pharmacokinetics|June 22, 2024
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059Jen-Hao Wu, Edoardo Pennesi, Francisco Bautista, et al.
Cell|March 5, 2013
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastomaMatija Snuderl, Ana Batista, Nathaniel D Kirkpatrick, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancerSteven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
Frontiers in Oncology|June 5, 2012
The first European interdisciplinary ewing sarcoma research summitHeinrich Kovar, Javier Alonso, Pierre Aman, et al.
Nature Communications|June 25, 2025
ETMR stem-like state and chemo-resistance are supported by perivascular cells at single-cell resolutionFlavia W de Faria, Nicole C Riedel, Daniel Münter, et al.
The Lancet. Oncology|April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysisAndrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patientsAndrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
Oncotarget|January 24, 2016
The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex diseaseHeinrich Kovar, James Amatruda, Erika Brunet, et al.
Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.
Pageof 15